Reclaim the Energy, Radiance & Mental Clarity
Your Cells Have Been Losing

Midlife energy crashes are linked to declining mitochondrial function, falling NAD+ levels, and accumulating senescent cells. As cellular energy production slows, the brain and muscles receive less ATP — felt as afternoon fatigue and brain fog.

Estrogen decline reduces collagen production and skin hydration, while oxidative stress and inflammation damage skin cells. Lower NAD+ also impairs the cellular repair processes that maintain skin elasticity and radiance.

Zombie cells (senescent cells) stop dividing but refuse to die, releasing inflammatory signals (SASP) that damage neighboring tissue. They accumulate with age and hormonal shifts, accelerating skin aging, joint discomfort, and metabolic dysfunction.

Estrogen supports mitochondrial efficiency; its decline reduces mitochondrial biogenesis and increases oxidative stress. This contributes to fatigue, slower metabolism, and reduced cellular repair during and after menopause.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme essential for energy production, DNA repair, and sirtuin signaling. Levels fall ~50% between ages 40–60, driven by rising CD38 activity, PARP hyperactivation, and lower NAMPT expression.

Geroscience research shows that targeting the mechanisms of aging — clearing senescent cells, restoring mitophagy, and replenishing NAD+ — can support cellular function. Lifestyle (exercise, sleep, nutrition) plus targeted compounds are the core strategy.

Fisetin is a flavonoid with senolytic properties shown in preclinical studies to selectively clear senescent cells. By reducing the inflammatory SASP burden, it may support skin, tissue, and metabolic health during aging.

Urolithin A is a postbiotic from pomegranate ellagitannins that activates mitophagy — the recycling of damaged mitochondria. Clinical trials show it improves muscle endurance and cellular energy markers in middle-aged adults.

NMN (nicotinamide mononucleotide) is a direct NAD+ precursor. It enters the salvage pathway to raise cellular NAD+, supporting sirtuin activity, DNA repair, and mitochondrial function. Human trials confirm NMN elevates blood NAD+.

ReCellence™ combines fisetin (senolytic), Urolithin A (mitophagy activator), and NMN (NAD+ precursor) to target the three core mechanisms of cellular aging simultaneously — senescent cells, mitochondrial dysfunction, and NAD+ depletion.

The ingredients are based on widely studied compounds with established safety profiles in human trials. As with any supplement, women who are pregnant, nursing, or on medication should consult their healthcare provider before use.

Cellular changes begin within weeks, but noticeable energy, skin, and clarity benefits typically develop over 30–90 days of consistent use as mitochondrial function and NAD+ levels are restored.

Yes. Urolithin A, fisetin, and NMN each have peer-reviewed clinical or preclinical evidence cited on this page, including trials in middle-aged and older adults.

There are no known interactions between these compounds and hormone therapy in the literature, but you should always consult your prescribing physician before combining supplements with any medication.

Regular aerobic and resistance exercise, 7–9 hours of sleep, a polyphenol-rich Mediterranean-style diet, stress management, and limiting alcohol and smoking all support mitochondrial health and complement cellular supplements.

Yes. Exercise is one of the most effective known stimulators of mitochondrial biogenesis, raising PGC-1α and improving oxidative capacity — benefits that persist across age groups including postmenopausal women.

Chronic low-grade inflammation ("inflammaging") rises with age and accelerates after menopause, driving CD38 expression that depletes NAD+ and promoting senescent cell accumulation that damages skin, brain, and metabolism.

Autophagy (and mitophagy) clears damaged proteins and mitochondria. This cellular recycling declines with age, contributing to the buildup that drives fatigue and tissue aging; compounds like Urolithin A reactivate it.

In clinical trials these compounds are generally well tolerated. Reported effects are typically mild and transient (e.g., minor GI discomfort). Individual responses vary; discontinue and consult a provider if you experience adverse effects.

Explore the Women's Science Library and full ReCellence Research Hub for evidence-based articles on mitochondrial health, oxidative stress, zombie cells, autophagy, NAD+ metabolism, and longevity ingredients.